Consolidating non profit organizations
A payment that a Federal awarding agency or pass through entity makes by any appropriate payment mechanism, including a predetermined payment schedule, before the non-Federal entity disburses the funds for program purposes.
This term has the same meaning as set forth in 13 CFR part 121 – Small Business Size Regulations, §121.103, “How does SBA determine affliliation? Includes: (1) projects relating to the etiology, epidemiology, natural history, diagnosis, treatment, or prevention of AIDS; (2) various sequelae specifically associated with the syndrome; and (3) preparation and screening of anti-AIDS agents as well as vaccine development, including both preclinical and clinical studies.
Those receipts that offset or reduce direct or indirect costs.
Typical examples of such transactions include purchase discounts, rebates, or allowances; recoveries or indemnities on losses, insurance refunds; and adjustments of overpayments or erroneous charges.
Applicants are urged to take note of the yearly NIH Plan for HIV-Related Research and indicate how their application addresses the NIH priorities set forth in that Plan.
The Plan can be found on the NIH Office of AIDS Research homepage The process of assigning a cost, or a group of costs, to one or more cost objective(s), in reasonable proportion to the benefit provided or other equitable relationship.
A 3-character code used to identify a specific category of extramural research activity, applied to financial assistance mechanisms.
Grant award stimulating research at health professional academic institutions with not more than million per year of NIH support in total costs in each of four or more of the last seven years. An individual typically in the grantee organization's central research administration office designated by a SO to facilitate the administration of NIH e RA Commons accounts.” Further information about SBA’s affiliation rules and a guide on affiliation is available at Not all applications examining various influences on T-lymphocytes or retroviruses will be appropriate for the expedited AIDS review process.Applications only indirectly related to AIDS will be evaluated by established Scientific Review Groups (SRGs) appropriate to the scientific discipline during regular NIH review cycles and should not be submitted in response to the expedited AIDS receipt dates.The process may entail assigning a cost(s) directly to a final cost objective or through one or more intermediate cost objectives.For additional information, see A cost incurred by a recipient that is: (1) reasonable for the performance of the award; (2) allocable; (3) in conformance with any limitations or exclusions set forth in the Federal cost principles applicable to the organization incurring the cost or in the No A as to the type or amount of cost; (4) consistent with regulations, policies, and procedures of the recipient that are applied uniformly to both federally supported and other activities of the organization; (5) accorded consistent treatment as a direct or indirect cost; (6) determined in accordance with generally accepted accounting principles; and (7) not included as a cost in any other federally supported award (unless specifically authorized by statute).